产品名称
三甲双酮, European Pharmacopoeia (EP) Reference Standard
InChI
1S/C6H9NO3/c1-6(2)4(8)7(3)5(9)10-6/h1-3H3
SMILES string
CN1C(=O)OC(C)(C)C1=O
InChI key
IRYJRGCIQBGHIV-UHFFFAOYSA-N
grade
pharmaceutical primary standard
API family
trimethadione
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
Gene Information
human ... CACNA1G(8913), CACNA1H(8912), CACNA1I(8911)
正在寻找类似产品? 访问 产品对比指南
Application
Trimethadione EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Other Notes
Sales restrictions may apply.
Packaging
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Repr. 1B
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
[Fetal trimethadione effects].
Y Nakane
Ryoikibetsu shokogun shirizu, (30 Pt 5)(30 Pt 5), 94-95 (2000-11-01)
E Tanaka et al.
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology, 104(2), 205-207 (1993-02-01)
1. Trimethadione (TMO) has the properties required of probe drugs for the evaluation of hepatic oxidizing capacity in vivo. 2. TMO is demethylated to dimethadione (DMO), its only metabolite, in the liver after oral administration. 3. In rats with various
[Fetal trimethadione syndrome].
T Nagai
Ryoikibetsu shokogun shirizu, (33)(33), 704-704 (2001-07-21)
E Tanaka et al.
Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology, 115(3), 211-216 (1996-11-01)
Trimethadione (TMO) has the properties required of probe drugs for the evaluation of hepatic drug-oxidizing capacity in humans in vivo. TMO is demethylated to dimethadione (DMO), its only metabolite, in the liver after oral administration. Involvement of two cytochrome P450's--CYP2C9
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持